← All trials
NCT06452498
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2024
- Primary completion
- Apr 30, 2028
- Completion date
- Jul 31, 2028
- First posted
- Jun 11, 2024
- Last posted
- Jun 11, 2024
- Enrollment
- 180
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Free University of AmsterdamLead sponsor
- Free University of AmsterdamOfficial
- Free University of AmsterdamSponsor investigator
- ZonMw: The Netherlands Organisation for Health Research and DevelopmentCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.